AIF1 and Stroke: The percentage of Iba1+ cells labeled with BrdU was reduced by 2.8-fold in the brains of clenbuterol-treated mice (Fig. 3a, b), suggesting that clenbuterol treatment following stroke reduces microglia/MDM proliferation and numbers surrounding the stroke.